Log In
Print
BCIQ
Print
Print this Print this
 

RQ-00000004

  Manage Alerts
Collapse Summary General Information
Company RaQualia Pharma Inc.
DescriptionPotassium competitive acid pump antagonist that inhibits binding of potassium ion to H+/K ATPase
Molecular Target H+/K ATPase pump
Mechanism of ActionH+/K+ ATPase pump inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationGastroesophageal reflux disease (GERD)
Indication DetailsTreat gastroesophageal reflux disease (GERD)
Regulatory Designation

Partner

CJ Group


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today